VamstarEffectively Navigating Loss of Exclusivity in PharmaceuticalsWhen pharmaceutical patents expire, the resulting loss of exclusivity (LOE) presents a significant challenge. Companies often experience…Jun 4Jun 4
VamstarShaping Your Key Account Management (KAM) Strategy using Environmental, Social, and Governance…The European medical technology (MedTech) landscape is undergoing a significant shift. ESG factors are no longer just buzzwords; they’re…Mar 19Mar 19
VamstarGaining a Competitive Edge: AI Powered Market Intelligence in European PharmaIn the ever-shifting landscape of the European pharmaceutical market, suppliers who wield the power of AI-driven market intelligence gain a…Mar 6Mar 6
VamstarGlobal Interventional Cardiology Market Report Preview (2024 Update)The realm of interventional cardiology (IC) stands at the cusp of a transformative era, marked by rapid technological advancements…Mar 4Mar 4
VamstarRising Importance of Global Health Initiatives in the Pharmaceutical Industry: Trends, Challenges…Leading pharmaceutical companies are increasingly focusing on global health initiatives, which has led to a rise in procurement through…Jan 29Jan 29